A new therapeutic approach in medullary thyroid cancer treatment: inhibition of oncogenic RET signaling by adenoviral vector-mediated expression of a dominant-negative RET mutant.

Source:http://linkedlifedata.com/resource/pubmed/id/12490846

Download in:

View as

General Info

PMID
12490846